We are live on ! Find out more
CIP

Convergence Investment Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
+0.77%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.26%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$729M
AUM Growth
-$28.5M
Cap. Flow
-$22.1M
Cap. Flow %
-3.03%
Top 10 Hldgs %
14.5%
Holding
474
New
110
Increased
97
Reduced
134
Closed
118

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$7.64M
2
SIR
SELECT INCOME REIT
SIR
+$5.78M
3
CDP icon
COPT Defense Properties
CDP
+$5.65M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.33M
5
HPQ icon
HP
HPQ
+$5.02M

Top Sells

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$6.55M
2
C icon
Citigroup
C
+$5.72M
3
MSFT icon
Microsoft
MSFT
+$5.28M
4
META icon
Meta Platforms (Facebook)
META
+$4.72M
5
WCG
Wellcare Health Plans, Inc.
WCG
+$4.29M

Sector Composition

Rank Sector Weight
1 Technology 14.61%
2 Financials 14.2%
3 Healthcare 11.97%
4 Industrials 11.15%
5 Energy 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWX
126
DELISTED
Time Warner Inc
TWX
$2.25M 0.31%
+29,928
New +$2.32M
COR icon
127
Cencora
COR
$61.2B
$2.24M 0.31%
29,005
-7,721
-21% -$587K
ALB icon
128
Albemarle
ALB
$15.1B
$2.22M 0.3%
+37,648
New +$2.45M
GMED icon
129
Globus Medical
GMED
$11.2B
$2.18M 0.3%
+110,730
New +$2.28M
THOR
130
DELISTED
THORATEC CORPORATION
THOR
$2.16M 0.3%
+80,670
New +$2.29M
VRTV
131
DELISTED
VERITIV CORPORATION
VRTV
$2.14M 0.29%
+42,722
New +$1.81M
OMED
132
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$2.12M 0.29%
111,945
+83,230
+290% +$1.67M
LM
133
DELISTED
Legg Mason, Inc.
LM
$2.1M 0.29%
41,113
-30,169
-42% -$1.5M
ENTA icon
134
Enanta Pharmaceuticals
ENTA
$396M
$2.1M 0.29%
+53,130
New +$2.12M
KFY icon
135
Korn Ferry
KFY
$4.28B
$2.07M 0.28%
83,142
+56,228
+209% +$1.65M
WMT icon
136
Walmart Inc
WMT
$887B
$2.06M 0.28%
80,934
+243
+0.3% +$6.14K
SPXC icon
137
SPX Corp
SPXC
$10.8B
$2.04M 0.28%
86,075
+62,185
+260% +$1.62M
TRGP icon
138
Targa Resources
TRGP
$56.2B
$2.03M 0.28%
+14,920
New +$2.05M
AES icon
139
AES
AES
$10.5B
$2M 0.27%
141,145
-1,351
-0.9% -$20.1K
TRN icon
140
Trinity Industries
TRN
$2.39B
$1.98M 0.27%
58,787
-8,163
-12% -$270K
NP
141
DELISTED
Neenah, Inc. Common Stock
NP
$1.96M 0.27%
+36,714
New +$1.97M
AZPN
142
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$1.96M 0.27%
51,819
– –
PCRX icon
143
Pacira BioSciences
PCRX
$1B
$1.95M 0.27%
+20,115
New +$1.96M
ED icon
144
Consolidated Edison
ED
$40B
$1.9M 0.26%
33,560
+26
+0.1% +$1.48K
AMKR icon
145
Amkor Technology
AMKR
$13.6B
$1.86M 0.25%
220,861
-55,470
-20% -$548K
ALK icon
146
Alaska Air
ALK
$5.63B
$1.85M 0.25%
+42,451
New +$1.97M
CLF icon
147
Cleveland-Cliffs
CLF
$6.98B
$1.81M 0.25%
+174,250
New +$2.67M
OVTI
148
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
$1.81M 0.25%
68,272
-3,208
-4% -$80.3K
LO
149
DELISTED
LORILLARD INC COM STK
LO
$1.8M 0.25%
30,131
-757
-2% -$45.9K
MRVL icon
150
Marvell Technology
MRVL
$194B
$1.79M 0.25%
132,714
+20,801
+19% +$286K
4 5
6
7 8

Similar funds

MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
HW
HORAN Wealth Cincinnati, Ohio $1.05B AUM 17.67% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
CIA
Compass Ion Advisors Conshohocken, Pennsylvania $1.05B AUM 16.28% 1-Year Est. Return

Convergence Investment Partners's Q3 2014 Portfolio in Review

As of Q3 2014, Convergence Investment Partners held 474 positions worth $729M, down 3.8% from $758M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Convergence Investment Partners withdrew a net $22.1M in Q3 2014, closing 118 positions and reducing 134 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $4.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Convergence Investment Partners opened a new position in Gilead Sciences worth $8.31M.

  • Convergence Investment Partners's largest Q3 2014 buy was Gilead Sciences: 78,065 shares worth $8.31M.
  • Convergence Investment Partners added most to Alphabet (Google) Class C in Q3 2014, an estimated $5.33M increase.
  • Convergence Investment Partners's biggest Q3 2014 reduction was ConocoPhillips, cutting an estimated $6.55M.
  • Convergence Investment Partners fully exited Wellcare Health Plans, Inc. in Q3 2014, selling an estimated $4.29M.
  • Convergence Investment Partners's ten largest holdings make up 15% of its $729M portfolio in Q3 2014.
  • Convergence Investment Partners opened 110 new positions and closed 118 in Q3 2014.
  • Convergence Investment Partners's portfolio value fell 3.8% quarter-over-quarter to $729M.

Based on Convergence Investment Partners's 13F filing for Q3 2014, filed 12 Nov 2014.